Bone Biologics Corp

Medical device company · Burlington, Massachusetts, United States · Nasdaq: BBLG

Bone Biologics Corp is a medical device company headquartered in Burlington, Massachusetts, United States. Its shares trade on Nasdaq under the ticker BBLG. It has reported private securities offerings to the US SEC, most recently $729,000 sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Bone Biologics at a glance

Typemedical device company
HeadquartersBurlington, Massachusetts, United States
Stock listingNasdaq: BBLG
SEC industryOrthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK1419554

What does Bone Biologics do?

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $729,000 sold (2023).

Frequently asked questions about Bone Biologics

Where is Bone Biologics headquartered?

Bone Biologics Corp is headquartered in Burlington, Massachusetts, United States.

What does Bone Biologics do?

Bone Biologics Corp is a medical device company. Its SEC industry classification is Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Is Bone Biologics a public company?

Yes. Bone Biologics Corp trades on Nasdaq under the ticker BBLG.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences